@showtime.trades: Moderna surged over 120% today. Not on earnings. Not on a partnership. On a Phase 3 cancer vaccine trial result that’s never been done before. A personalized mRNA vaccine built from a patient’s own tumor DNA... paired with Merck’s Keytruda... kept melanoma patients cancer-free longer than any existing treatment. First time a therapy like this has succeeded at Phase 3. The full data hasn’t been released yet. That’s the risk. Full breakdown in the video. Follow the page and type discord in the comments to see how I’m thinking about this one! Not financial advice. Do your own research. #StockMarket #MRNA #Biotech #Investing #stocks